REYULTI Trademark

Trademark Overview


On Tuesday, January 9, 2018, a trademark application was filed for REYULTI with the United States Patent and Trademark Office. The USPTO has given the REYULTI trademark a serial number of 87748107. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, April 13, 2019. This trademark is owned by H. Lundbeck A/S. The REYULTI trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, cancer, migraine, pain, alcoholism and dependency; di...
reyulti

General Information


Serial Number87748107
Word MarkREYULTI
Filing DateTuesday, January 9, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, April 13, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesVaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, cancer, migraine, pain, alcoholism and dependency; diagnostic agents, reagents, preparations and substances for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 23, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address2500 Valby
DK

Trademark Events


Event DateEvent Description
Monday, April 15, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, April 13, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, September 12, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 12, 2018NON-FINAL ACTION E-MAILED
Wednesday, September 12, 2018NON-FINAL ACTION WRITTEN
Monday, September 10, 2018LETTER OF PROTEST EVIDENCE FORWARDED
Monday, September 10, 2018LETTER OF PROTEST EVIDENCE FORWARDED
Wednesday, August 22, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 22, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 21, 2018ASSIGNED TO LIE
Monday, July 30, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 31, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 31, 2018NON-FINAL ACTION E-MAILED
Wednesday, January 31, 2018NON-FINAL ACTION WRITTEN
Friday, January 26, 2018ASSIGNED TO EXAMINER
Tuesday, January 23, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 12, 2018NEW APPLICATION ENTERED IN TRAM